|
![]() |
||
|
|
|
» Apply for a Grant
- FAQs - Young Investigator - Independent Investigator - Distinguished Investigator - Staglin Award » Grantee List - Young Investigators - Independent Investigators - Distinguished Investigators - Staglin Awards
» Prizes
- Lieber Prize - Falcone Prize - Ruane Prize - Goldman-Rakic Prize - Freedman Award - Klerman Award » For Grantees - Young Investigator Fact Sheet - Independent Investigator Fact Sheet - Distinguished Investigator Fact Sheet - Staglin Award Fact Sheet
|
E. David Leonardo, M.D., Ph.D. (Young Investigator 2004) of New York State Psychiatric Institute/Columbia University, proposes a study in a mouse model to clarify why selective serotonin reuptake inhibitors (SSRIs) require weeks before their clinical effects are evident. Recent evidence from Dr. Leonardo and others shows the effect of SSRIs requires signaling through a certain serotonin receptor, 5-HT1A, which leads to new nerve growth in the dentate gyrus of the hippocampus. The birth of new neurons and new connections occurs in time frame consistent with the drug’s effect. But other studies reveal that the dorsal, or back, part of hippocampus may be involved in learning and memory while the ventral, or front, portion is key to emotion processing. Dr. Leonardo proposes to test whether neurogenesis in the ventral but not dorsal hippocampus is required for antidepressant response in animal models of depression and anxiety, thereby further elucidating the mechanism of action of these drugs. Program Area: MOOD DISORDERS\Unipolar Depression |
Announcements
NARSAD Award Winners
Latest News from NARSAD
|